Marie Abate
Vanderveen RP, Abate MA, Haxby D. A literature evaluation course delivered via computer assisted instruction, electronic mail, and teleconferences: a case description. Am J Pharm Educ 1999;63:178-182.
Abate MA. Reactions to the Study, In: Study Commission on Pharmacy: A Road Map to a Profession's Future. Worthen DB, Ed., Gordon & Breach: Amsterdam, 1999, pp. 87-104.
Abate MA, Ponte CD. Diarrhea case study, In: Pharmacotherapy: A Patient-Focused Approach. 2nd ed. Schwinghammer TL, Ed., Appleton & Lange: Connecticut, 1999.
Mayur Amonkar
Amonkar MM, Madhavan S, Rosenbluth S and Simon K. Barriers and Facilitators to Providing Common Preventive Screening Services in Managed Care Settings. J Community Health, 1999:24(3);229-247.
Dawn Bell
"Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes." Bell DM. Pharmacotherapy 1999;19:1086-93
"Introduction, Definition, Diagnosis, Significance, Prevalence, Pathology, and Pathophysiology of Hypertension." Bell DM, In Hypertension (2nd ed.); R.Supernaw, ed., Pharmat Inc., 1999.
"Rash in patients receiving ticlopidine therapy after intracoronary stent placement." Whetzel TR, Bell DM. Pharmacotherapy 1999;19:228-231.
"An Appalachian Perspective on Modifiable Coronary Heart Disease Risk Factors: How Well Are We Doing?" Halperin AK, Elnicki DM, Palmer HC, See CJ, Nuss M, Kolar MM, Bell DM. Southern Medical Journal 1999;92:174-189.
Patrick Callery
M.J. Egorin, E.G. Zuhowski, D.L. Sentz, J.M. Dobson, P.S. Callery, and J.L. Eiseman, Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent, Cancer Chemother. Pharmacol., 44, 283-294 (1999).
Teresa Dunsworth
Dunsworth TS. Drug and Practice Regulatory Issues. In: Carter, B., Lake, K., Raebel, M., et al., Eds. Pharmacotherapy Self Assessment Program, 3rd edition. Kansas City, MO: American College of Clinical Pharmacy. Pages 25-52 in Book A, 17-20 in book B.
Greenly R, Dunsworth TS. Drugs in Lactation. Mother Baby Journal 1999;4:7-12.
David Elliott
Elliott, D.P., Corkrean, J.E., Diabetic Complications, In "Pharmacotherapy Casebook, 2nd Edition" Schwinghammer, T. L. Appleton & Lange: Stamford, CT
Elliott D.P., Medication Compliance: Issues & Considerations, The Older Patient, 1999;4 (2).
Peter Gannett
Gannett, P.M., Powell, J., Rao, R., Shi, X., Lawson, T., Kolar, C., and Toth, B. C8-Aryladenine formation in calf thymus DNA from arenediazonium ions. (1999) Chem. Res. Toxicol. 12:297-304.
Toth, B., Patil,K., Erickson, J., Gannett, P. Cancer Induction Studies Using Different Administrations of Benzenediazonium Sulfate in Mice (1999) In Vivo 13:125-128.
Makarov,S.V., Mundoma, C., Svarovsky, S.A., Shi, X., Gannett, P.M., Simoyi, R.H., Reactive Oxygen Species in the Aerobic Decomposition of Sodium Hydroxymethanesulfinate. (1999) Arch. Biochem. Biophys. 367: 289-296.
Gerald Higa
Higa GM, Sarkar MA, DeVore RF, Pharmacodynamic profile of prolonged etoposide administration in patients with small cell lung cancer and non-Hodgkin's lymphoma. Pharmacotherapy, 1999;19(1):101-7.
Jennifer Justice
Justice, JH, Kuhn, RJ. Current Treatment Options in Acute Otitis Media. US Pharmacist, March 1999, 71-82.
Barbara Kaplan-Machlis
Kaplan-Machlis B, Wandstrat TL, Beane JS. Cost effectiveness of five oral antimicrobials for acute otitis media. Value in Health 1999;2(3):186A.
Kaplan-Machlis B, Speigler J, Revicki DA. Health-related quality of life in primary care patients with gastroesophageal reflux disease. Ann Pharmacother 1999;33:1032-6.
Swain RA, Kaplan-Machlis B. Therapeutic Use of Vitamin E in Prevention of Atherosclerosis. Alternative Med Review 1999;4:414-23.
Swain RA, Kaplan-Machlis B. Magnesium for the Next Millennium. Southern Med J 1999;92(11):1040-7.
Kaplan-Machlis B, Klostermeyer BS. New Drug Development: Safer NSAIDs B The COX-2 Inhibitors. Ann Pharmacother 1999:33:979-88.
Wandstrat TL, Kaplan-Machlis B, Temple M, Nahata MC. Tetravalent rotavirus vaccine. Ann Pharmacother 1999;33:833-9.
Lilly C, Kaplan-Machlis B. Lamotrigine use in pregnancy. J Pharm Technol; 1999; 15:75-8.
David Lalka
Barnette K.G., Sarkar M.A., Glover D.D., Li P., Boyd C., Lalka D. Glutathione S-Transferase in human endometrium: Quantitation and interindividual variability in isoform content,Gynecol; Obstet Invest (1999)47:114-119.
Kovacs P., Edwards D.J., Lalka D., Scheiwe W.M. and Stoeckel K., High-dose omeprazone: Use of multiple-dose study design to assess bioequivalance and accuracy of CYP2C19 phenotyping, Therap Drug Monit. (1999) 21: 526-531.
Du Souich P. and Lalka D. Pharmacokinetics: Development of an Exquisitely Practical
Science, Prous Science, Barcelona and Philadelphia , 1999.
Kristy Lucas
Lucas KH, Schliesser SH, O'Neil MG. Shaking, Chills, and Rigors with Once-Daily
Gentamicin. Phamacotherapy 1999;19(9):1102-4.
Lucas, KH, Kaplan-Machlis, B. Singulair (montelukast sodium) New Drug Update.
1999; 5 (3): 1-3.
Joseph Ma
Ma, J.Y.C., Barger, M.W., Castranova, V., and Ma, J.K.H., "Use of tetrandrine to differentiate between mechanisms involved in silica- versus bleomycin-induced fibrosis," J. Toxicol. Envir. Health, 56:247-266, 1999.
Yang, H.M., Barger, M.W., Castranova, V., Ma, J.K.H., Yang, J.J., and Ma, J.Y.C., "Effects of diesel exhaust particles (DEP), carbon black, and silica on macrophage responses to lipopolysaccharide: Evidence of DEP suppression of macrophage activity," J. Toxicol. Envir. Health, 58:261-278, 1999.
Suresh Madhavan
Amonkar, M.M., Madhavan, S.S., Rosenbluth, S., and Simon, K. "Barriers and Facilitators to Providing Common Preventive Screening Services in Managed Care Settings". J. Community Health, 1999:24(3);229-247.
Gore, P., Madhavan, S.S., Curry, D., McClung, G., Castiglia, M., Rosenbluth. S.A. Smego, R. "Predictors of Childhood Immunization Completion in a Rural Population". Social Science & Medicine; (1999)48: 1011-1027.
David Nau
Nau DP. West Virginia University and Health Plan Collaborate for Disease Management.
J. Managed Care Pharmacy 1999;5:467.
Ried LD, Nau DP, Grainger-Rousseau TJ. Evaluation of Patients' Health-Related Quality of Life using a modified and shortened version of the Living with Asthma Questionnaire (ms-LWAQ) and the medical outcomes study, Short-Form 36 (SF-36). Quality of Life Research 1999;8:491-99.
Charles Ponte
Ponte CD. Managed care and the pharmacy profession revisited. J. Managed Care Pharmacy (March/April 1999; Vol. 5, No. 2)
Abate MA and Ponte CD. Diarrhea (Chapter 28), in Pharmacotherapy Casebook - A Patient- Focused Approach, 2nd Ed., T.L . Schwinghammer, ed., Appleton & Lange, Stamford, Conn. pp. 92-94 (Instructor's Guide, pp. 102-105)
Ponte CD. Bacterial vaginosis (Chapter 113), in Pharamcotherapy Casebook - A Patient-Focused Approach, 2nd Ed., T. Schwinghammer, ed., Appleton & Lange, Stamford, Conn., pp. 280-82 (Instructor's Guide - pp. 364-67)
Yongyut Rojanasakul
Rojanasakul, Y., Ye, J., Chen, F., Castranova, V., Vallyathan, V., Shi, X. (1999) Dependence of Nuclear Transcription (NF)-kB Activation and Free Radical Generation on TNFa Production in Macrophages. Mol. Cell Biochem. 200, 119-125.
Cheng, N., Shi, X., Ye, J., Castranova, V., Chen, F., Leonard, S.S., Vallyathan, V., Rojanasakul, Y. (1999) Role of Transcription Factor NF-kB in Asbestos-Induced TNFa Response from Macrophages. Exp. Mol. Pathol. 66, 201-210.
Ye, J., Wang, S., Leonard, S.S., Sun, Y., Butterworth, L., Antonini, J., Ding, M., Rojanasakul, Y., Vallyathan, V., Castranova, V., Shi, X. (1999) Role of Reactive Oxygen Species and p53 in Chromium(VI)-Induced Apoptosis. J. Biol. Chem. 274, 34974-34980.
Rojanasakul, Y. (1999) Basic Elements of Molecular Biology. In: Biopharmaceutical Drug Design and Development, S. Wu-Pong and Y. Rojanasakul (eds.), Humanna Press, Totowa, NJ, pp. 21-35.
Rojanasakul, Y. and Dokka, S. (1999) Tools for Molecular Analysis. In: Biopharmaceutical Drug Design and Development, S. Wu-Pong and Y. Rojanasakul (eds.), Humanna Press, Totowa, NJ, pp. 37-49.
Chen, F., Lu, Y., Castranova, V., Rojanasakul, Y., Vallyathan, V., Shi, X., Demers, L.M. (1999) Nitric Oxide Inhibits HIV Tat-Induced NF-kB Activation. Am. J. Pathol. 155, 275-284.
Ye, J., Shi, X., Jones, W., Rojanasakul, Y., Cheng, N., Schwegler-Berry, D., Baron, P., Deye, G., Li, C., Castranova, V. (1999) Critical Role of Glass Fiber Length in TNFa Production and Transcription Factor Activation in Macrophages. Am. J. Physiol. 276, L426-L434.
Sidney Alan Rosenbluth
Amonkar, M.M., Madhavan, S., Rosenbluth, S.A., Simon, K.J., "Barriers and Facilitators To Providing Common Preventive Screening Services in Managed Care Settings", J. Community Health; (1999) 24(3): 229-247.
Gore, P., Madhavan, S., Curry, D., McClung, G., Castiglia, J., Rosenbluth, S.A., Smego, R., "Predictors of Childhood Immunization Completion in a Rural Population", Social Science & Medicine: (1999) 48: 1011-1027.
Elizabeth Scharman
Durback-Morris, LF, Scharman, EJ., "Accidental Administration of Phenol", Vet. Hum. Toxicol. (1999) 41:157.
Durback-Morris, LF, Scharman, EJ., "Charcoal for Overdoses", Am. J. Nursing (1999) 99:14-15 (Letters to Editor)
Douglas Slain
Slain D. Lipid-based amphotericin B for the treatment of fungal infections. Pharmacotherapy 1999 Mar;19(3):306-23.
George Spratto
Spratto, George R. and Woods, Adrienne L. PDR - Nurses Drug Handbook, 2000 Edition, Medical Economics Co., Albany, NY, July, 1999.
Mary Stamatakis
Stamatakis, M.K., Joy, M.S., Updates in Chronic Renal Failure and Hemodialysis, In Pharmacotherapy Self-Assessment Program III Carter, B, Ed., American College of Clinical Pharmacy: Kansas City, MO, 1999.
Stamatakis, M.K., Meyer-Stout, P.J., Disintegration Performance of Renal Multivitamin Supplements, J Renal Nutr. (1999) 9:78-83.
Stamatakis, M.K., Leader, W.G., Tracy, T.S., Stability of High-Dose Vancomycin and Ceftazidime in Peritoneal Dialysis Solutions, Am J Health-Syst Pharm. (1999) 56:246-8.
Stamatakis M.K., Dialysis of drugs, In: Basic Bibliographies. Hospital Pharmacy. (1999) 34(12):1482.
Paula Jo Meyer Stout
"Disintegration Performance of Renal Multivitamin Supplements", M. Stamatakis and P. J. Meyer Stout, J. Renal Nutrition, Vol. 9 No. 2, April 1999, pp 78-83.
Grazyna Szklarz
Strobel, S.M., Szklarz, G.D., He, Y., Foroozesh, M., Alworth, W.L., Roberts, E.S., Hollenberg P.F. and Halpert, J.R. 1999. Identification of selective mechanism-based inactivators of cytochromes P450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility. J. Pharmacol. Exp. Therap. 290: 445-451, 1999.
Timothy Tracy
Tracy, T.S., Korzekwa, K.R., Gonzalez, F.J., Wainer, I.W. "Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil", Br. J. Clin. Pharmacol. (1999) 47:545-552.
Stamatakis, M.K., Leader, W.G., Tracy, T.S., "Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solution", Am. J. Hosp. Pharm. (1999) 56:246-248.
Schmidt, R.J., Yokota, S., Tracy, T.S., Sorkin, M.I., Baylis, C. "Nitric oxide production is low in end stage renal disease patients on peritoneal dialysis", Am. J. Physiol. (Renal), (1999) 276 (Renal Physiol. 45):F794-F797.
Schmidt RJ, Domico J, Samsell LS, Yokota S, Tracy TS, Sorkin MI, Engels K, Baylis C. Indices of activity of the nitric oxide system in patients on hemodialysis, Am. J. Kidney Dis., 34: 228-234.
Zhang, W., Parenteau, H., Greenly, R.L., Metz, C.A., Aggarwal, S., Wainer, I.W., Tracy, T.S., "Effect of Protein-Calorie Malnutrition on Cytochromes P450 and Glutathione S-Transferase", Eur. J. Drug Metab. Pharmacokin. (1999) 24:141-147.
Tara Whetsel
Whetsel TR, Bell DM. Rash in patients receiving ticlopidine after intracoronary stent placement. Pharmacotherapy 1999;19:228-31.
